BRIEF published on 03/16/2026 at 09:40, 8 hours 28 minutes ago JP Morgan Chase reduces its stake in Inventiva Actions Participation Crossing Thresholds JP Morgan Inventiva
BRIEF published on 03/12/2026 at 15:56, 4 days 2 hours ago Threshold Crossing at Inventiva Actions Stock Market Crossing Thresholds JP Morgan Chase & Co. Inventiva
BRIEF published on 02/17/2026 at 14:32, 27 days 3 hours ago Threshold Crossing by Deep Track Biotechnology Voting Rights Actions Threshold Crossing Inventiva Deep Track
BRIEF published on 02/17/2026 at 08:35, 27 days 9 hours ago Inventiva Reports Preliminary Financial Results for 2025 Financial Results Cash Flow Biopharmaceuticals Inventiva MASH
BRIEF published on 02/17/2026 at 08:35, 27 days 9 hours ago Inventiva announces its preliminary financial results for 2025 Financial Results Treasury Biopharmaceutical Public Offering Inventiva
PRESS RELEASE published on 02/17/2026 at 08:30, 27 days 9 hours ago Inventiva reports preliminary 2025¹ fiscal year financial results Inventiva reports preliminary 2025 fiscal year financial results, showing €99.3 million in cash, €131.6 million in short-term deposits, and €4.5 million in revenues Revenues Financial Results Clinical-stage Inventiva Cash Equivalents
BRIEF published on 02/04/2026 at 22:05, 1 month 11 days ago Inventiva at the Guggenheim Biotech Summit 2026 New York Inventiva MASH Lanifibranor Biotech Summit
BRIEF published on 02/04/2026 at 22:05, 1 month 11 days ago Inventiva to Participate in Guggenheim Biotech Summit 2026 Biopharmaceuticals Inventiva MASH Lanifibranor Biotech Summit
PRESS RELEASE published on 02/04/2026 at 22:00, 1 month 11 days ago Inventiva to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 Inventiva to present at Guggenheim Emerging Outlook: Biotech Summit 2026. CEO Andrew Obenshain to participate in fireside chat on February 11, 2026, in New York City Fireside Chat Inventiva Biotech Summit Guggenheim Emerging Outlook CEO Andrew Obenshain
BRIEF published on 01/30/2026 at 11:21, 1 month 17 days ago JP Morgan Chase & Co.'s reduced stake in INVENTIVA Shares Threshold Crossing Right To Vote JP Morgan Inventiva
Published on 03/16/2026 at 14:00, 4 hours 9 minutes ago Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression
Published on 03/16/2026 at 13:45, 4 hours 24 minutes ago iFabric Corp Provides Strong 2025 Revenue Estimate and 2026 Outlook
Published on 03/16/2026 at 13:30, 4 hours 39 minutes ago Ondas Completes Acquisition of Rotron Aerospace Ltd., Expanding Long-Range Propulsion Technologies for Advanced Unmanned Systems for Defense
Published on 03/16/2026 at 13:30, 4 hours 39 minutes ago An Asteroid Just Hit Earth - Where Did Everything Land? New Global Challenge Seeks Answers
Published on 03/16/2026 at 13:30, 4 hours 39 minutes ago Tactical Resources Signs Agreement to Acquire the Sierra Blanca Quarry and Tailings Access for the Peak Rare Earth Project
Published on 03/16/2026 at 17:15, 54 minutes ago EU Council Removes Niels Troost from Russia Sanctions List
Published on 03/16/2026 at 15:47, 2 hours 21 minutes ago EQS-Adhoc: CEWE Stiftung & Co. KGaA: CEWE plans 17th dividend increase in a row
Published on 03/16/2026 at 18:00, 9 minutes ago Disclosure of trading in own shares from 09/03/2026 to 13/03/2026
Published on 03/16/2026 at 17:58, 11 minutes ago Aéroports de Paris S.A - February 2026 traffic figures
Published on 03/16/2026 at 17:56, 12 minutes ago Reporting on share buyback transactions carried out between March 9 and March 13, 2026
Published on 03/16/2026 at 17:35, 34 minutes ago Disclosure of transactions in own shares from March 9 to March 13, 2026
